Alemtuzumab treatment in Denmark

Best Practice Nordic | Sep 2019 | ECTRIMS 2019 |

Asta Theodorsdottir prsent data from the The Danish Multiple Sclerosis Registry about the demographics of the alemtuzumab-treated population in Denmark; the treatment strategy; the number of cycles and its relation to previous disease modifying treatments (DMTs); and the frequency of switch to other DMTs.